✦ LIBER ✦

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

✍ Scribed by Swain, S. M.; Tang, G.; Geyer, C. E.; Rastogi, P.; Atkins, J. N.; Donnellan, P. P.; Fehrenbacher, L.; Azar, C. A.; Robidoux, A.; Polikoff, J. A.; Brufsky, A. M.; Biggs, D. D.; Levine, E. A.; Zapas, J. L.; Provencher, L.; Northfelt, D. W.; Paik, S.; Costantino, J. P.; Mamounas, E. P.; Wolmark, N.

Book ID: 121366235
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 777 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.48.1275

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic and Predictive Value of Tumor

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

✍ Loi, S.; Sirtaine, N.; Piette, F.; Salgado, R.; Viale, G.; Van Eenoo, F.; Rouas, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 313 KB

Adjuvant chemotherapy and timing of tamo

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

✍ Kathy S Albain; William E Barlow; Peter M Ravdin; William B Farrar; Gary V Burto 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 145 KB

1–36 The Use of Alternate, Non-Cross-Res

1–36 The Use of Alternate, Non-Cross-Resistant Adjuvant Chemotherapy on the Basis of Pathologic Response to a Neoadjuvant Doxorubicin-Based Regimen in Women With Operable Breast Cancer: Long-term Results From a Prospective Randomized Trial

✍ TL, Smith 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 66 KB

762 Prognostic and Predictive Value of T

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

✍ M. Olivier; L. Fernández-Cuesta; C. Oakman; E. Quinaux; M.S. Dolci; P.A. Francis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 71 KB

PREPARE trial: a randomized phase III tr

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel darbepoetin alfa in primary breast cancer--results at the time of surgery

✍ Untch, M.; Fasching, P. A.; Konecny, G. E.; von Koch, F.; Conrad, U.; Fett, W.; 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 234 KB

Cardiac safety analysis of the first sta

Cardiac safety analysis of the first stage of NSABP B-31, a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) to that of AC followed by paclitaxel plus trastuzumab (TH) in patients (pts) with operable, node-positive (N+), HER-2 overexpressing breast cancer (HER2+BC)

✍ C Geyer; J Bryant; E Romond; E Tan-Chiu; M Ewer; D Keefe; R Shannon; G Yothers; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 541 KB